JP2017516777A5 - - Google Patents

Download PDF

Info

Publication number
JP2017516777A5
JP2017516777A5 JP2016568934A JP2016568934A JP2017516777A5 JP 2017516777 A5 JP2017516777 A5 JP 2017516777A5 JP 2016568934 A JP2016568934 A JP 2016568934A JP 2016568934 A JP2016568934 A JP 2016568934A JP 2017516777 A5 JP2017516777 A5 JP 2017516777A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
subject
infection
oxazino
oxazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016568934A
Other languages
English (en)
Japanese (ja)
Other versions
JP6502387B2 (ja
JP2017516777A (ja
JP6502387B6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/001585 external-priority patent/WO2015181637A1/en
Publication of JP2017516777A publication Critical patent/JP2017516777A/ja
Publication of JP2017516777A5 publication Critical patent/JP2017516777A5/ja
Publication of JP6502387B2 publication Critical patent/JP6502387B2/ja
Application granted granted Critical
Publication of JP6502387B6 publication Critical patent/JP6502387B6/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016568934A 2014-05-29 2015-05-27 細菌感染の治療のための融合スピロ環ヘテロ芳香族化合物 Expired - Fee Related JP6502387B6 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462004246P 2014-05-29 2014-05-29
US62/004,246 2014-05-29
PCT/IB2015/001585 WO2015181637A1 (en) 2014-05-29 2015-05-27 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections

Publications (4)

Publication Number Publication Date
JP2017516777A JP2017516777A (ja) 2017-06-22
JP2017516777A5 true JP2017516777A5 (https=) 2018-06-07
JP6502387B2 JP6502387B2 (ja) 2019-04-17
JP6502387B6 JP6502387B6 (ja) 2019-05-29

Family

ID=54329851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016568934A Expired - Fee Related JP6502387B6 (ja) 2014-05-29 2015-05-27 細菌感染の治療のための融合スピロ環ヘテロ芳香族化合物

Country Status (14)

Country Link
US (1) US10238661B2 (https=)
EP (1) EP3148546A1 (https=)
JP (1) JP6502387B6 (https=)
KR (1) KR20170007818A (https=)
CN (1) CN106659725A (https=)
AU (1) AU2015265620B2 (https=)
CA (1) CA2948438A1 (https=)
EA (1) EA033459B1 (https=)
IL (1) IL248838B (https=)
MX (1) MX365261B (https=)
PH (1) PH12016502271B1 (https=)
SG (2) SG10201906842WA (https=)
TW (1) TWI657818B (https=)
WO (1) WO2015181637A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109111465B (zh) * 2017-06-22 2021-01-12 中国科学院上海药物研究所 噻唑烷酮螺嘧啶三酮类化合物及制备方法和用途
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP3833665B1 (en) 2018-08-09 2023-07-19 Antabio SAS Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
JP2007502307A (ja) 2003-08-15 2007-02-08 アストラゼネカ アクチボラグ グルタミン酸ラセマーゼ（ｍｕｒｉ）の阻害剤としての縮合複素環
CA2606847A1 (en) 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US20100261719A1 (en) 2007-07-02 2010-10-14 Gregory Steven Basarab Chemical compounds
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
CN102245605B (zh) * 2008-10-14 2016-01-27 阿斯利康(瑞典)有限公司 用于治疗细菌感染的稠合、螺环杂芳族化合物
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections

Similar Documents

Publication Publication Date Title
Álvarez-Paino et al. Effect of glycounits on the antimicrobial properties and toxicity behavior of polymers based on quaternized DMAEMA
JP2010174030A5 (https=)
EP3050876A3 (en) Kinase modulators
EP3584308A3 (en) Compositions and methods
WO2012083017A3 (en) Controlled release oral dosage forms of poorly soluble drugs and uses thereof
EP4596041A3 (en) Farnesoid x receptor agonists and uses thereof
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
BR112013013525A2 (pt) formulação de liberação controlada sólida de lacosamida para administração oral, composição farmacêutica sólida, e, método para a prevenção, alívio e/ou tratamento de uma doença do sistema nervoso central
WO2017087608A8 (en) Modulators of ror-gamma
EP2911695C0 (en) COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE BY SELECTIVE DELIVERY OF OLIGONUCLEOTIDE MOLECULES TO SPECIFIC TYPES OF NEURONS
EP4344742A3 (en) Valbenazine salts and polymorphs thereof
NZ603457A (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
WO2015095241A3 (en) Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
WO2014180889A8 (en) Methods and compositions for the treatment of cancer
EP2528603A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING PAIN AND OTHER DISPLAYS
FR2937972B1 (fr) Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
BRPI1010948A2 (pt) Composição compreendendo pelo menos trans- cinamaldeído e a respectiva utilização no tratamento das infecções bacterianas, mais particularmente no tratamento das doenças nosocomiais.
HK1205939A1 (en) Parenteral formulations for administering macrolide antibiotics
EP4242240A3 (en) Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments
JP2018500387A5 (https=)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法
JP2017519730A5 (https=)
EP4613333A3 (en) Pharmaceutical compositions comprising akt protein kinase inhibitors
WO2017117070A8 (en) Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof